Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-031386

SVP, Chief Accounting Officer sold 142 shares at $113.67 ($16,141)

From the SEC's structured data for this filing

Trades in this filing

Huizenga Theodore Alan · SVP, Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-06 Sale : show line 1 in the form −142 $113.67 $16,141 15,031 D
Open-market sales · 142 sh · avg $113.67 · $16,141
Loading xslF345X03/doc4.xml…